Site Search
Google Search
search button

Breaking News:

House Judiciary Chairman Jerry Nadler Issues Subpoena for Full, Unredacted Mueller Report     - | -     Senate Intelligence Chair Reported Russia Probe Status to White House After Comey Briefing     - | -     Even Barr Has Russia Connections, Yet He Didn't Recuse Himself      - | -     2020 Democratic Candidates Go After Barr and Mueller Report Release      - | -     North Korea Announces First Testing of Guided Weapon Since Breakdown in Talks with Trump      - | -     Barr Claims No Evidence of Obstruction, But Mueller Says It's Up to Congress     - | -     After Learning Mueller Was Appointed Special Counsel, Trump Predicted End of Presidency and Said, 'I'm F---ed'     - | -     GOP Congressman Invokes 'The Deep State'
Sanofi And Regeneron Cut List Price Of Cholesterol Drug By 60 Percent
Get Business & Technology Alerts

viewsViews 127
11 Feb 2019 03:42 PM EST

Sanofi and Regeneron Pharmaceuticals said they will slash the U.S. list price of their potent but expensive cholesterol fighter Praluent by 60 percent. Reuters reports the new list price for Praluent will be $5,850 a year, matching the price Amgen set when it lowered the list of its competing drug, Repatha, in October. Sanofi and Regeneron said they expect the lower-priced Praluent to be available for pharmacies to order in early March. They said the new price should improve patient access and result in lower out-of-pocket costs for U.S. consumers.

Post Your Comment
Excellent Very Good Good Fair Poor



Recently Posted Comments
FREE
AllMediaNY AllMediaNY AllMedaiNY